Introduction
Malignant cell transformation results from changes in the delicate balance between positive and negative growth controls. Whereas many studies have focused on the role of oncogenes and tumor suppressor genes in the control of cell proliferation, an increasing number of reports have examined the role that the inhibition of cell death plays in oncogenesis (reviewed in Homan and Liebermann, 1994; Thompson, 1995) . Apoptosis, also referred to as programmed cell death, is an inducible cellular response to developmental or environmental stimuli that ultimately results in the cleavage of chromatin and cell death (Wyllie et al., 1980; reviewed in Thompson, 1995; White, 1996) . Although this process is essential for normal development, its dysregulation is associated with a variety of disorders. Increased susceptibility to cell death can result in embryonic lethality and neurodegenerative disorders, whereas increased cell survival is conducive to autoimmune diseases and cancer (reviewed in Thompson, 1995) .
Several recent reports have implicated the Rel/NFkB family of transcription factors in the promotion or the inhibition of apoptosis (Abbadie et al., 1993; Beg et al., 1995; Beg and Baltimore, 1996; Cai et al., 1997; Grimm et al., 1996; Liu et al., 1996; Neiman et al., 1991; Van Antwerp et al., 1996; Wang et al., 1996; White et al., 1995; Wu et al., 1996 ; W-X Zong, J Bash and C GeÂ linas, in preparation). This family of proteins includes the v-Rel oncoprotein of the oncogenic Rev-T retrovirus, its avian and mammalian cellular homologs c-Rel, RelA, RelB, p105/NFkB1, p100/NFkB2, Xenopus X-Rel1 and the Drosophila Dorsal, Dif and Relish factors (reviewed in Verma et al., 1995) . In agreement with their important role in cell physiology, the regulation of these factors allows for a rapid response to external stimuli. The activation of Rel dimers associated with one of several IkB inhibitors in the cytoplasm of unstimulated cells results in the phosphorylation and rapid degradation of IkB through the ubiquitin-proteasome pathway (reviewed in Thanos and Maniatis, 1995) . The nuclear entry of active NF-kB complexes is followed by their binding to kB DNA sites and the activation of speci®c genes through C-terminal transactivation domains (reviewed in Baeuerle and Henkel, 1994; Siebenlist et al., 1994) .
Whereas v-Rel immortalizes and transforms lymphoid cells in chickens and transgenic mice, rearrangements and ampli®cations of the c-rel and rel-related nfkb2 genes have been associated with lymphomagenesis in humans (reviewed in Luque and GeÂ linas, 1997) . These observations emphasize the concept that the dysregulation of Rel proteins may be an important factor in the development or progression of malignancy. The study of v-Rel-induced cell transformation is thus likely to help to clarify the mechanisms by which the Rel proteins function in oncogenesis.
Although the pathway through which v-Rel transforms cells is not fully understood, it is interesting to note that cells transformed by temperature-sensitive mutants of v-Rel undergo apoptosis at the nonpermissive temperature, suggesting a role for v-Rel in blocking programmed cell death (White et al., 1995) . In the present study, we used a tetracycline-regulated system to conditionally express the wild-type v-Rel protein and to directly address its role in cell transformation and programmed cell death. Our studies demonstrate that v-Rel can block programmed cell death in response to dierent stimuli and in dierent cell systems, and suggest that its antiapoptotic activity may be an important component of its transforming function.
Results

Conditional transformation of primary chicken spleen cells by the tetracycline-regulated expression of v-Rel
A tetracycline-regulated system was used to characterize the eects of v-Rel on lymphoid cell proliferation and transformation. In this system, a fusion protein comprised of the tetracycline repressor fused to the activation domain of the transcriptional activator VP16 protein of Herpes simplex virus served as a tetracycline transactivator (tTA) to regulate the expression of v-Rel (Gossen and Bujard, 1992) . To eciently target primary chicken spleen cells with this system, the tetracycline-regulated v-rel cassette was introduced into a spleen necrosis virus (SNV)-derived vector (pJD214, Dougherty and Temin, 1986) . In this context, the tTA activator was expressed under the control of the SNV long terminal repeat (LTR) promoter, whereas v-rel was under the control of a tetracycline-regulated minimal Cytomegalovirus (CMV) promoter (214tTA-v-rel, Figure 1a ). Addition of tetracycline to the cell culture medium was used to terminate v-Rel transcription, by blocking association of the tTA activator with the operator sites positioned upstream of the CMV promoter. A construct constitutively expressing v-Rel from the SNV LTR promoter was used to control for possible side-eects of tetracycline on cell cultures (214-v-rel; Figure 1a ; Bhat and Temin, 1990) .
Transformed cell clones expressing v-Rel under constitutive or tetracycline-regulated control were established from primary chicken spleen cells. As shown in Table 1 , the expression of v-Rel under the control of the tetracycline-regulated system led to the ecient transformation of chicken spleen cells (214tTA-v-rel). The transformation frequency observed with this vector was four-fold lower than that observed when v-Rel was directly expressed from the SNV LTR promoter (214-v-rel) , presumably due to dierences in the strength of the promoters. As anticipated, the control 214-b10 plasmid that does not express any Rel protein failed to induce cell transformation, as it gave rise to a single abortive colony that could not be propagated in liquid culture (Table 1; McDonnell et al., 1992) .
Nineteen independent tTA-v-Rel transformed spleen cell clones were picked and analysed for the expression of v-Rel. The detailed characterization of representative clones tTA-v-Rel10 and tTA-v-Rel2 follows. As shown in Figure 1b , v-Rel was expressed at high levels in tTA-v-Rel clones maintained in the absence of tetracycline (lanes 5, 9). The addition of tetracycline to the culture medium of these cells markedly decreased the expression of v-Rel within 24 h after the addition of the drug (Figure 1b , compare lanes 5 ± 8, 9 ± 12). The fact that tetracycline had no inhibitory eect on the expression of v-Rel from the constitutive SNV-LTR promoter indicated the speci®c repression of v-Rel under tetracycline-regulated control, and argued against a cytotoxic eect of the drug (v-Rel102 cells; Figure 1b , lanes 1 ± 4). The down-modulation of v-Rel by tetracycline in spleen cell clones tTA-v-Rel2 and tTA-v-Rel10 was representative of ®ve independent clones analysed (data not shown).
Growth properties of tetracycline-regulated v-Reltransformed spleen cells
The growth and morphology of tTA-v-Rel10 spleen cells maintained in the absence of tetracycline were very similar to those of v-Rel102 cells transformed by the constitutive expression of v-rel. tTA-v-Rel cell clones grew as large non-adherent aggregates that showed an average doubling time of approximately 2.5 days (Figure 2a ). The addition of tetracycline to the control v-Rel102 cells had no signi®cant eect on their morphology or growth rate (Figure 2a and b, panels a ± d). On the contrary, the cell aggregates in the tetracycline-regulated tTA-v-Rel cultures dispersed into individual cells within 24 h after the addition of the drug (tTA-v-Rel10, Figure 2b , panels e ± h). This change in morphology correlated with the cessation of cell proliferation (Figure 2a) . We next examined whether death occurred through apoptosis. Since DNA degradation is a hallmark of programmed cell death, cellular genomic DNA was analysed for nucleosomal DNA fragmentation. The addition of tetracycline to the culture medium of tTAv-Rel10 cells rapidly induced DNA fragmentation into nucleosomal ladders (Figure 3a , compare lanes 5 to 6 ± 8). In contrast, no fragmentation was observed with the control v-Rel102 cells cultured in the presence or absence of the drug ( Figure 3a , lanes 1 ± 4). To further con®rm that the repression of v-Rel expression led to apoptosis in transformed spleen cells, a TUNEL assay was performed. As shown in Figure 3b , the repression of v-Rel expression in the tTA-v-Rel2 and tTA-v-Rel10 cell clones led to a signi®cant increase in the number of cells containing fragmented DNA, as indicated by the signi®cant increase in log¯uorescence (compare panels g ± j and l ± o to panels b ± e).
Together, these experiments indicated that the repression of v-Rel in transformed spleen cells resulted in apoptosis and raised the possibility that v-Rel may transform lymphoid cells by rescuing them from programmed cell death. According to this model, one would predict that apoptosis should occur in primary spleen cells cultured under conditions identical to those used to transform cells with v-Rel. To address this issue, primary chicken spleen cells were cultured as they would normally be in a transformation assay, and their genomic DNA was analysed by electrophoresis. As shown in Figure 3c , the DNA was relatively intact at 6 h after the isolation of cells from the spleen, which represents the time point when v-Rel DNA would normally be electroporated into the cells (lane 1). In contrast, signi®cant DNA fragmentation was observed at the 72 h time point following the extraction of the spleen, when the cells would normally be plated into soft agar (Figure 3c , lane 2). This result further suggested that the expression of v-Rel in primary spleen cells correlates with the inhibition of apoptosis that naturally occurs upon the in vitro cultivation of primary chicken spleen cells.
Analysis of apoptosis inhibitors in v-Rel transformed spleen cells
The sharp decrease in spleen cell viability observed in the absence of v-Rel expression raised the possibility that v-Rel may be required for the expression of endogenous inhibitors of the apoptotic process. Immunoblot analysis was used to examine whether the repression of v-Rel in transformed spleen cells correlated with changes in the expression of some of these factors. The expression of the apoptosis inhibitors Bcl-2 and Bcl-X L was investigated in tTA-v-Rel2 and tTA-v-Rel10 spleen cell clones cultured in the presence of tetracycline to repress the expression of v-Rel.
Both Bcl-2 and Bcl-X L were expressed at equivalent levels in tTA-v-Rel cell clones maintained in the absence of tetracycline, and in the control v-Rel102 cells that constitutively expressed v-Rel (Figure 4 , lanes 1, 5 and 9). The addition of tetracycline led to a speci®c decrease in the steady-state levels of these two factors in tTA-v-Rel cell clones, but not in the control v-Rel102 cells (compare lanes 5 ± 12 to 1 ± 4). It is important to note however that the decrease in the levels of Bcl-2 and Bcl-X L were only observed after the onset of apoptosis. Whereas DNA fragmentation was evident within 24 h after the addition of tetracycline (Figure 3a , lane 6), changes in the endogenous levels of Bcl-2 and Bcl-X L were only detected between 24 and 48 h following the addition of the drug (Figure 4 , lanes 5 ± 12). No such changes were observed with the control anti-a-actin antibody (Figure 4 , bottom panel). To con®rm that the disappearance of these apoptosis inhibitors was not directly related to that of v-Rel, we examined the levels of endogenous p40/ IkBa factors in v-Rel-transformed spleen cells. Like other IkB factors, p40/IkBa is stabilized by its association with v-Rel and is rapidly degraded in the absence of Rel/NF-kB proteins (reviewed in Thanos and Maniatis, 1995; Verma et al., 1995) . As shown in Figure 4 , the repression of v-Rel in the tTA-v-Rel cell clones led to the rapid disappearance of p40/IkBa with kinetics that paralleled that of v-Rel itself (lanes 5 ± 12). The disappearance of the Bcl-2 and Bcl-X L proteins therefore diered markedly from those of IkBa and v-Rel, and occurred subsequently to the observation of DNA fragmentation and cell death. Combined, these experiments suggested that the apoptosis associated with changes in the level of v-Rel expression involves a mechanism distinct from changes in the steady-state levels of Bcl-2 and Bcl-X L . The delayed alteration in the steady-state levels of these proteins observed in these cells may thus represent a secondary consequence of the cell death.
v-Rel blocks TNFa-induced apoptosis in HeLa cells
Our observation that the onset of apoptosis following the repression of v-Rel in transformed spleen cells preceded changes in the levels of Bcl-2 and Bcl-X L raised the possibility that v-Rel may exert its eect at other steps in the pathway and possibly in response to dierent stimuli. To address this issue, we investigated whether v-Rel could also promote the survival of cells induced to undergo apoptosis by a dierent stimulus, such as cell treatment with tumor necrosis factor alpha (TNFa).
TNFa is a well characterized inducer of apoptosis. In human HeLa cells, this cytokine induces massive cell death in combination with the protein synthesis inhibitor cycloheximide (CHX; Holtmann et al., 1988; Rubin et al., 1988) . To examine whether v-Rel could protect HeLa cells from TNFa-induced cell death, we used the tetracycline-regulated system to conditionally express v-Rel in the HeLa-derived HtTA-1 cell line (Gossen and Bujard, 1992) . The inducible expression of v-Rel in cell clone HtTA-v-Rel48 was analysed in immunoblots. Whereas the protein was undetectable in cells maintained in the presence of tetracycline, the removal of the drug led to the detection of v-Rel within 24 h and to its progressive accumulation thereafter (Figure 5a , lanes 4 ± 6). As anticipated, v-Rel was not detected in the parental HtTA-1 cells cultured in the presence or absence of tetracycline (Figure 5a , lanes 1 ± 3). DNA binding assays con®rmed that the v-Rel protein produced in this system was functional for binding to the IL2Ra NF-kB DNA site (data not shown).
As anticipated, the addition of TNFa together with CHX to the culture medium of control HtTA-1 cells resulted in massive cell death (Figure 5b , compare panels a, c to b, d). Similarly, TNFa plus CHX treatment of HtTA-v-Rel48 cells cultured in the presence of tetracycline to repress v-Rel expression resulted in a dramatic loss of cell viability (Figure 5b , panels f ± g). In agreement with previous studies showing that the cytotoxic eect of TNFa on many cell types is only evident upon the inhibition of RNA or protein synthesis, the addition of CHX or TNFa alone had no such eect (data not shown; Holtmann et al., 1988; Rubin et al., 1988) . Interestingly, the induction of v-Rel expression in HtTA-v-Rel48 cells led to signi®cant protection from cytolysis by TNFa and CHX (Figure 5b , panels h ± j). This protective eect was observed at all TNFa concentrations tested, ranging from 20 to 2000 units per ml. In agreement with the survival of v-Rel-expressing cells, the expression of the protein suppressed TNFa-induced DNA degradation (data not shown). In contrast, the 
Discussion
This study shows that the tetracycline-regulated expression of v-Rel in primary chicken spleen cells leads to the conditional manifestation of its transforming phenotype. Whereas the repression of v-Rel synthesis resulted in rapid lymphoid cell death by apoptosis, its expression enabled the cells to escape this fate. Expression of the protein in the HeLa-derived HtTA-1 cell line provided direct evidence that v-Rel inhibits programmed cell death, as it blocked TNFainduced apoptosis. While the repression of v-Rel expression in lymphoid cells was accompanied by the rapid degradation of IkBa, changes in the steady-state levels of the Bcl-2 and Bcl-X L inhibitors of apoptosis were only observed following the onset of cell death. This suggests that v-Rel may function through other inhibitors of apoptosis or at other steps in the death pathway. Together, these ®ndings support the hypothesis that the anti-apoptotic activity of v-Rel is important for its transforming function.
Rel proteins and programmed cell death
The fact that the inducible expression of v-Rel in HtTA-1 cells conferred protection from TNFa-induced cell death demonstrates that v-Rel can block apoptosis induced by dierent stimuli. Interestingly, other Rel and NF-kB factors were recently implicated in the control of programmed cell death. While some studies suggested a pro-active role for these proteins in cell death, others have attributed to them an anti-apoptotic function (Abbadie et al., 1993; Beg et al., 1995; Beg and Baltimore, 1996; Cai et al., 1997; Grimm et al., 1996; Liu et al., 1996; Neiman et al., 1991; Van Antwerp et al., 1996; Wang et al., 1996; White et al., 1995; Wu et al., 1996 ; W-X Zong, J Bash and C GeÂ linas, in preparation).
Our experiments demonstrating that v-Rel prevents apoptosis in primary chicken spleen cells and protects cells from TNFa-induced cytolysis agree with the latter ®ndings, suggesting an anti-apoptotic activity. Meanwhile, it is important to realize that the actual role of NFkB factors in the apoptosis pathway may be quite complex, and that their ability to accelerate or attenuate apoptosis may vary in dierent cell types or in response to dierent death-inducing stimuli. The mechanism by which v-Rel inhibits programmed cell death remains to be determined. While a previous study showed no change in Bcl-2 protein levels when cells transformed by temperature-sensitive mutants of v-Rel underwent apoptosis (White et al., 1995) , our assays revealed a signi®cant decrease in the steadystate levels of Bcl-2 and Bcl-X L . However, it is interesting to note that the disappearance of these two proteins was only observed after the onset of death in our tetracycline-regulated lymphoid cells. Although we can not rule out a possible eect of v-Rel on the expression of other members of the expanding Bcl-2 family, our data suggests that v-Rel is unlikely to block apoptosis by regulating the expression of Bcl-2 and Bcl-X L . v-Rel may rather aect their activity or perhaps substitute for their protective eect. Future experiments will undoubtedly help to position v-Rel within the apoptotic pathway.
The IkBa inhibitor and cellular apoptosis
Most of the endogenous p40/IkBa population in transformed chicken spleen cells is found in a complex with v-Rel and is stabilized by this interaction (Davis et al., 1990b; Simek and Rice, 1988; Morrison et al., 1989) . The stabilization of p40/IkBa that we observed in response to the induction of v-Rel in HtTA-v-Rel48 cells supports these ®ndings (data not shown). It is therefore not surprising to ®nd the parallel disappearance of p40/IkBa and v-Rel upon the addition of tetracycline to our conditionally transformed spleen cells ( Figure  4) . Interestingly, no degradation intermediates of IkBa were detected in our immunoblots with antip40 antibodies raised against the full-length protein (Davis et al., 1990a) . This is in contrast to the N-terminal truncation and partial degradation of IkBa that was observed in cells transformed by the conditional G37E ts mutant of v-Rel shifted to the non-permissive temperature (White et al., 1995; . The degradation intermediate of IkBa observed with this mutant may perhaps re¯ect a slightly dierent interaction of v-Rel with IkBa as a result of the mutation adjacent to the Rel DNA-binding motif (White et al., 1995) .
The role of the v-Rel/IkBa interaction in apoptosis and cell transformation has yet to be clari®ed. However, accumulating evidence argues against the possibility that v-Rel functions by titrating endogenous IkBa, thereby allowing other NF-kB subunits to block apoptosis and function in cell transformation. For instance, while the transformed thymocytes of v-Rel transgenic mice contain appreciable amounts of v-Rel-IkBa complexes, the nuclear levels of c-Rel, RelA and p52 are comparable to those observed in wild-type mice (Carrasco et al., 1996) . Similarly, v-Rel mutants that fail to eciently interact with IkBa retain the ability to transform spleen cells ; I Luque and C GeÂ linas, unpublished data). Moreover, immunoblot analysis of nuclear extracts from tetracycline-regulated HtTAv-Rel48 cells showed no change in the localization of endogenous pools of RelA (data not shown). Combined, these ®ndings argue against the titration of endogenous pools of IkBa as an important mechanism to enhance the anti-apoptotic and transforming activities of v-Rel.
Apoptosis and cell transformation
While v-Rel immortalized and transformed lymphoid cells and prevented them from undergoing apoptosis, primary spleen cells cultured under conditions identical to those used in transformation assays failed to survive for more than a few days. This agrees with previous studies pointing to a correlation between the expression of v-Rel in transformed avian bursal lymphocytes and their resistance to apoptosis induced by cell dispersion and g-irradiation (Neiman et al., 1991) . Similarly, the expression of temperaturesensitive (ts) mutants of v-Rel in transformed spleen cells correlated with conditional resistance to apoptosis at the permissive temperature (White et al., 1995) . Although it could be argued that the apoptotic phenotype previously observed with v-Rel mutants could result from a gain-of-function brought about by the mutations, our ®ndings with an inducible expression system for the wild-type v-Rel protein dispute this argument. The demonstration that the continuous expression of wild-type v-Rel is necessary to initiate and maintain cell transformation therefore supports the validity of these previous observations (Boehmelt et al., 1992 (Boehmelt et al., , 1995 White and Gilmore, 1993; Capobianco and Gilmore, 1993; White et al., 1995) . It is interesting to note that our immunoblot and TUNEL assays of transformed spleen cells showed a correlation between the level of v-Rel expression and the extent of nuclear DNA fragmentation ( Figure 1b and Figure 3b ). This suggests that a threshold of v-Rel expression is necessary to prevent spontaneous DNA fragmentation in cultured spleen cells and agrees with recent studies indicating that a certain level of v-Rel synthesis is required to achieve cell transformation (Sachdev et al., 1997; .
The ability of v-Rel to block apoptosis supports a model whereby the constitutive expression of this activity may prevent the elimination of cells that would normally die. This is consistent with the ability of v-Rel to extend the lifespan of primary chicken embryo ®broblasts in culture (Morrison et al., 1991; Kralova et al., 1994) . It is thus tempting to speculate that v-Rel may transform lymphoid cells by rescuing them from apoptosis. This also raises the possibility that the chromosomal rearrangement and ampli®cation of its cellular homolog c-rel in human lymphomas may perhaps increase its ability to prevent cell death (Houldsworth et al., 1996; Lu et al., 1991) . Future studies will help to address these issues.
Although the mechanism by which v-Rel functions remains to be clari®ed, previous work from our group and others demonstrated that its DNA-binding and transcriptional activities are required for cell transformation (reviewed in Gilmore et al., 1996) . It will therefore be interesting to determine whether its antiapoptotic activity also involves the speci®c activation of cellular gene expression. Recent experiments from our laboratory suggest that the DNA-binding and transcriptional activities of v-Rel are indeed necessary to block TNFa-induced apoptosis (W-X Zong, J Bash and C GeÂ linas in preparation). The fact that TNFa-induced cytolysis is potentiated by the inhibition of RNA or protein synthesis (Holtmann et al., 1988) suggests that Rel/NF-kB-regulated genes may participate in the pathway to block cell death. The tetracycline-regulated cell systems described herein will thus help to identify genes under the transcriptional control of v-Rel that may be important for its anti-apoptotic and/or transforming functions.
Materials and methods
Plasmids v-rel was conditionally expressed using a tetracyclineregulated system (Gossen and Bujard, 1992) . 214-v-rel constitutively expressed the v-Rel protein of Rev-T under the control of the spleen necrosis virus (SNV) long terminal repeat (LTR) promoter (Bhat and Temin, 1990) . 214-tTA-vrel is an SNV-derived retroviral vector that expresses the tTA activator protein from the SNV LTR promoter of pJD214 (Dougherty and Temin, 1986) , together with the v-rel gene under the control of a minimal Cytomegalovirus (CMV) promoter with the heptamerized tetracycline operator sites from pUHD10-3 (Gossen and Bujard, 1992). A v-rel mutant that contains a stop codon positioned downstream of the initiating ATG of v-Rel was used as a negative control (214-b10; McDonnell et al., 1992) . SW253 DNA, that encodes the replication-competent reticuloendotheliosis virus strain A (Rev-A), was used to generate helper virus (Watanabe and Temin, 1983 ). pUHD10-3-v-rel expressed the v-rel gene under the control of the minimal CMV promoter and the heptamerized tetracycline operator sites of pUHD10-3. pHMR272 was used to confer resistance to the drug hygromycin B (Bernard et al., 1985) .
Cell culture and transfection
Chicken spleen cells were grown in Dulbecco's modi®ed Eagle's medium (DMEM) supplemented with 20% fetal bovine serum (FBS), 1% chicken serum, and antibiotics (100 units per ml of penicillin and 100 mg per ml of streptomycin). Cells were maintained at 40.58C in an atmosphere of 5.5% CO 2 . Primary chicken spleen cells were isolated from 3-weekold chickens. Cells were electroporated with 214-v-rel or 214tTA-v-rel DNA together with SW253 SNV helper virus DNA, as described (White and Gilmore, 1993) . Cells were cultured for 3 days to allow virus propagation and plated into soft agar (Gilmore and Temin, 1988) . Colonies of transformed cells were scored 14 days later and expanded in liquid culture. Cells were maintained in the presence or absence of tetracycline (2 mg per ml). Tetracycline-regulated spleen cell clones used in this study were designated tTA-vRel2 and tTA-v-Rel10. Transformed spleen cell clone vRel102 was derived by constitutive expression of v-Rel from the SNV LTR promoter.
HtTA-1 cells, that stably expressed the tTA activator protein, were a gift from Dr H Bujard (Gossen and Bujard, 1992) . The cells were grown in DMEM supplemented with 10% FBS, 2 mM L-glutamine, 16vitamin solution, 16non-essential amino acids, and antibiotics (100 units per ml of penicillin, 100 mg per ml streptomycin and 125 mg per ml of G418 in potency units). Cells were maintained at 378C in an atmosphere of 5% CO 2 . HtTA-1 cells were conditioned to tetracycline-HCl (2 mg per ml, Sigma) for 4 days prior to transfection. The cells were co-transfected with pUHD10-3-vRel and pHMR272, using a modi®ed calcium-phosphate procedure (Chen and Okayama, 1987) . Cell clones were selected in the presence of hygromycin B (225 units per ml, Calbiochem). Drug resistant colonies were picked and screened for the inducible expression of v-Rel. Cell clones were maintained in the presence of tetracycline (2 mg per ml) and refed every other day. Tetracycline-regulated HeLa cell clone HtTA-v-Rel48 was used in this study.
Immunoblotting
Immunoblotting was performed by enhanced chemiluminescence (ECL) (Amersham). Cell extracts were prepared in lysis buer (50 mM Tris HCl pH 7.5, 150 mM sodium chloride, 1% sodium deoxycholate, 1% Triton X-100, 10 mg per ml of leupeptin, 10 mg per ml pepstatin, 20 mg per ml aprotinin, 10 mM sodium pyrophosphate, 50 mM sodium¯uoride and 0.5 mM sodium orthovanadate; Resnitzky et al., 1994) . Extracts were quantitated for total protein concentration using the method of Bradford (1976) . The v-Rel protein was detected using a rabbit polyclonal antibody #1967, speci®c for its unique N-terminus (Xu et al., 1993) . Rabbit polyclonal anti-Bcl-2 antibody #S-006 was a gift from Dr S Haldar (Haldar et al., 1989) . Polyclonal antibodies against full-length chicken p40/IkBa were a gift from Dr H Bose. Polyclonal antibodies against Bcl-X L and aactin were also used.
Flow cytometry analysis
Cells were pelleted, washed twice with PBS and ®xed in cold 70% ethanol for 30 min at 7208C. After centrifugation, the cells were incubated in 2N HCl, 0.5% Triton X-100 at room temperature for 30 min. Cells were neutralized in 0.1 M Na 2 B 4 O 7 pH 8.5. The suspension was washed with 0.5% Tween-20 plus 1% BSA in PBS, prior to incubation in PBS containing 10 mg per ml propidium iodide. Cells were analysed by¯ow cytometry using the ModFit program for cell cycle analysis.
DNA fragmentation assay
Nucleosomal fragmentation was detected as described (Smith et al., 1989) . Cells (5610 6 ) were lysed in Sarcosyl buer (100 mM Tris-HCl pH 8.0, 20 mM EDTA, and 1% laurylsarcosine), and incubated with an equal volume of proteinase K at 1 mg per ml for 2 h at 508C. RNase A was added to a ®nal concentration of 250 mg per ml and extracts were further incubated at 508C for 90 min. After phenol/ chloroform extraction, the aqueous phase was removed and the DNA was precipitated with 10 mM MgCl 2 , 1/10 volume of 3 M sodium acetate, and 2.5 volumes of absolute ethanol. The DNA was resolved by 1% agarose gel electrophoresis and revealed by ethidium bromide staining.
TUNEL assay
Terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL) assays were performed as described, with some modi®cations (Gavrieli et al., 1992) . Cells were ®xed in 1% paraformaldehyde in PBS on ice for 15 min. The cells were washed in PBS containing 1.25 mg per ml BSA and incubated in TdT buer (0.2 M potassium cacodylate, 25 mM Tris-HCl, 0.25 mg per ml bovine serum albumin; pH 6.6) containing 2.5 mM cobalt chloride, 20 mM biotin-16-dUTP and 0.1 units per ml TdT (terminal deoxynucleotidyl transferase, Boehringer Mannheim) for 1 h at 378C. After washing in PBS-0.125% BSA, the cells were incubated in staining buer (0.6 M NaCl, 60 mM sodium citrate, pH 7.0, 0.1% Triton X-100, 5% non-fat milk, and 6.2 ng per ml of avidin-FITC; Boehringer Mannheim) for 30 min at room temperature in the dark. Cell samples were washed in PBS-0.1% Triton X-100 and stained with propidium iodide (5 mg per ml) in PBS containing 0.1% RNase A for 10 min in the dark at 378C. Cells were analysed by¯ow cytometry using the Cell-Quest program.
TNFa-induced apoptosis assay
TNFa-induced apoptosis was analysed as previously described (White et al., 1992) . The HtTA-v-Rel48 cell clone and the parental HeLa-derived HtTA-1 cells (5610 5 cells per 10 cm dish) were maintained in the presence of tetracycline (2 mg per ml), or induced for tTA or v-Rel expression in the absence of the drug for 48 h. Cells were treated for 16 h with cycloheximide (30 mg per ml) and TNFa (20 ± 2000 units per ml) alone or together, and photographed.
